Novo Nordisk is seeking marketing authorization from the European Medicines Agency (EMA).

The entities involved

• Novo Nordisk →

  Danish pharmaceutical company

  • Eli Lilly and Company received full FDA approval, expanded a safety study into India, and broke ground on a new facility in Houston while competing in the GLP-1 market.Fri 19:45
  • Eli Lilly's tirzepatide proved more effective than Novo Nordisk's semaglutide in the obesity drug market.Thu 17:25
• European Medicines Agency →

  highest regulatory authority on medicines in the European Union

  • The European Medicines Agency is reviewing mRNA vaccine trials reported by Moderna and MSD.03:31
  • EMA adopted a negative opinion on MAA for Omeros Corporation, while Pomerantz LLP confirmed its global office locations.Thu 15:51

Related events

• Novo Nordisk and Astellas Pharma are noted as large-cap healthcare companies, with Novo Nordisk reporting higher revenue and earnings.Oct 23
• Omeros Corporation's drug received FDA approval and is currently undergoing review by the European Medicines Agency.Jun 26